Dyne Therapeutics (DYN) Enterprise Value (2020 - 2026)
Dyne Therapeutics' Enterprise Value came in at $2.78 billion for Q2 2026, up 587.4% from $404.58 million a year earlier and up 37.5% from the prior quarter.
Powered by 
Analysis
Dyne Therapeutics (DYN) Enterprise Value (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dyne Therapeutics reported Enterprise Value of -$93.53 million; for FY2025, it was $1.4 billion, down 20.7% from FY2024.
- Going back by year, Enterprise Value was $1.77 billion in FY2024 (+154.6%), $694.43 million in FY2023 (+78.6%), $388.82 million in FY2022 (+64.3%) and $236.59 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q3 2024.
- Year-over-year, Enterprise Value increased in four of the last eight quarters, with growth averaging 180.0%.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2023 (growth of 652.9%), and the weakest in Q2 2022 (a decline of 90.1%).
- Business Quant data shows DYN's Enterprise Value at $2.02 billion (Q1 2026), $1.4 billion (Q4 2025) and $1.01 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Dyne Therapeutics | 2.71 Bn | 2.71 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.78 Bn |
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 1.40 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 404.58 Mn |
| Mar 31, 2025 | 511.12 Mn |
| Dec 31, 2024 | 1.77 Bn |
| Sep 30, 2024 | 2.93 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Mar 31, 2024 | 2.02 Bn |
| Dec 31, 2023 | 694.43 Mn |
| Sep 30, 2023 | 391.62 Mn |
| Jun 30, 2023 | 478.67 Mn |
| Mar 31, 2023 | 433.47 Mn |
| Dec 31, 2022 | 388.82 Mn |
| Sep 30, 2022 | 411.07 Mn |
| Jun 30, 2022 | 63.58 Mn |
| Mar 31, 2022 | 174.75 Mn |
| Dec 31, 2021 | 236.59 Mn |
| Sep 30, 2021 | 428.57 Mn |
API Access
Dyne Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=DYN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();